Glucose effectiveness is strongly related to left ventricular mass in subjects with stage I hypertension or high-normal blood pressure

American Journal of Hypertension

Volumn 17, Issue 2, 2004, Pages 146-153

  Stiefel, Pablo ^a   Miranda, María L ^a   Rodríguez Puras, María José ^a   García Morillo, Salvador ^a   Carneado, Joaquín ^a   Pamies, Encarnacion ^a   Villar, José ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

Glucose effectiveness; Hypertension; Insulin resistance; Left ventricular mass; Minimal model

Indexed keywords

GLUCOSE;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLE; DISEASE MARKER; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; MALE; MEASUREMENT; PARAMETER; PATIENT; PREVALENCE; PRIORITY JOURNAL; SAMPLE;

EID: 1642575217     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjhyper.2003.09.015     Document Type: Article

References (33)

1. Ganau A., Devereux R.B., Pickering T.G., Roman M.J., Schnall P.L., Santucci S., Spitzer M.C., Laragh J.H. Relation of left ventricular hemodynamic load and contractile performance to left ventricular mass in hypertension. Circulation. 81:1990;25-36.
2. Frolich E.D., Tarazi R.C. Is arterial pressure the sole factor responsible for hypertensive cardiac hypertrophy? Am J Cardiol. 44:1979;959-963.
3. Natali A., Santoro D., Palombo C., Cerri M., Ghione S., Ferrannini E. Impaired insulin action on skeletal muscle metabolism in essential hypertension. Hypertension. 17:1991;170-178.
4. Saad M.F., Lillioja S., Nyomba B.L., Castillo C., Ferraro B., de Gregorio M. Racial differences between blood pressure and insulin resistance. N Engl J Med. 324:1991;733-739.
5. Zimmermman S., Phillips R.A., Dunaif A., Finegood D.T., Wilckenfeld C., Ardeljan M., Gorlin R., Krakoff L.R. Polycystic ovary syndrome lack of hypertension despite profound insulin resistance . J Clin Endocrinol Metab. 75:1992;508-551.
6. De Fronzo R.A., Tobin J.B., Andres R. Glucose clamp technique a method for quantifying insulin resistance . Am J Physiol. 237:1979;E214-E223.
7. Godsland I.F., Stevenson J.C. Insulin resistance syndrome or tendency . Lancet. 346:1995;100-103.
8. Bergman R.N., Prager R., Volund A., Olefsky J.M. Equivalence of the insulin sensitivity index in man derived by the minimal mode method and the euglycemic glucose clamp. J Clin Invest. 79:1987;790-800.
9. Buccolo R.J., Bergman R.N., Marsh D.J., Yates F.E. Dynamics of glucose autoregulation in the isolated blood-perfused canine liver. Am J Physiol. 227:1974;209-217.
10. Baron A.D., Kolterman O.G., Bell J., Mandarino L.J., Olefsky J.M. Rates of non-insulin-mediated glucose uptake are elevated in type II diabetic subjects. J Clin Invest. 76:1985;1782-1788.
11. Ader M., Pacini G., Yang Y.J., Bergman R.N. Importance of glucose per se to intravenous glucose tolerance comparison of the minimal model prediction with direct measurements . Diabetes. 34:1985;1092-1103.
12. Van Italie T.B. Health implications of overweight and obesity in the United States. Ann Intern Med. 103:1985;983-987.
13. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 20:1997;1183-1197.
14. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Arch Intern Med. 157:1997;2413-2446.
15. Moore C.R., Krakoff L.R., Phillips R.A. Confirmation or exclusion of stage I hypertension by ambulatory blood pressure monitoring. Hypertension. 29:1997;1109-1113.
16. Verdeccihia P., Porcellatu C., Scillaci G., Borgioni C., Ciucci A., Battistelli M., Guerrieri M., Gatteschi C., Zampi I., Santucci A. Ambulatory blood pressure an independent predictor of prognosis in essential hypertension . Hypertension. 24:1994;793-801.
17. Bergman R.N. Towards physiological understanding of glucose tolerance minimal-model approach . Diabetes. 38:1989;1512-1527.
18. Sahn D.J., De María A., Kisslo J., Weyman A. Committee on M-mode standardization of the American Society of Echocardiography recommendations regarding quantification in M-mode echocardiography. Results of a survey of echocardiographic measurements . Circulation. 58:1978;1072-1083.
19. Grossman E., Shemesh J., Shamiss A., Thaler M., Carroll J., Rosenthal T. Left ventricular mass in diabetes-hypertension. Arch Intern Med. 152:1992;1001-1004.
20. Felicio J.S., Ferreira S.R.G., Plavnik F.L., Moisés V., Kholmann O., Ribeiro A.B., Zanella M.T. Effect of blood glucose on left ventricular mass in patients with hypertension and type 2 diabetes mellitus. Am J Hypertens. 13:2000;1149-1154.
21. Devereux R.B., Alonso D.R., Lutas E.M., Gotlieb L.J., Campo E., Sachs I., Reicheck N. Echocardiographic assessment of left ventricular hypertrophy comparison to necropsy findings . Am J Cardiol. 57:1986;450-458.
22. Aeschbacher B.C., Hutter D., Fuhrer J., Weidmann P., Delacrétaz E., Allemann Y. Diastolic dysfunction precedes myocardial hypertrophy in the development of hypertension. Am J Hypertension. 14:2001;106-113.
23. Avignon A., du Cailar G., Ribstein J., Monniere L., Minram A. Left ventricular mass in the obese influence of lean body mass . Arch Mal Coeur. 90:1997;1043-1046.
24. Watanabe K., Sekiya M., Tsuruoka T., Funada J., Kameoka H. Effect of insulin resistance on left ventricular hypertrophy and dysfunction in essential hypertension. J Hypertens. 17:1999;1153-1160.
25. Yasunari K., Kohno M., Kano H., Yokokawa K., Horio T., Yoshikawa J. Possible involvement of phospholipase D and protein kinase C in vascular growth induced by elevated glucose concentration. Hypertension. 28:1996;159-168.
26. Yasunari K., Kohno M., Kano H., Yokokawa K., Horio T., Yoshikawa J. Aldose reductase inhibitor prevents hyperproliferation and hypertrophy of cultured rat vascular smooth muscle cells induced by high glucose. Arterioscler Thromb Vasc Biol. 15:1995;2207-2212.
27. Koya D., King G.L. Protein kinase C activation and the development of diabetic complications. Diabetes. 47:1998;859-866.
28. Srivastava A.K. High glucose-induced activation of protein kinase signaling pathways in vascular smooth muscle cells a potential role in the pathogenesis of vascular dysfunction in diabetes . Int J Mol Med. 9:2002;85-89.
29. Barbagallo M., Shan J., Pang P.K., Resnick L.M. Glucose-induced alterations in cytosolic free calcium in cultured tail artery vascular smooth muscle cells. J Clin Invest. 95:1995;763-767.
30. Barbagallo M., Gupta R.K., Resnick L.M. Cellular ions in NIDDM relation of calcium to hyperglycemia and cardiac mass . Diabetes Care. 19:1996;1393-1398.
31. Araujo-Villar D., García-Estevez D.A., Cabezas-Cerrato J. Insulin sensitivity, glucose effectiveness, and insulin secretion in nondiabetic offspring of patients with non-insulin-dependent diabetes mellitus a cross-sectional study . Metabolism. 48:1999;978-983.
32. Galvan A.Q., Galetta F., Natali A., Muscelli E., Sironi A.M., Cini G., Camastra S., Ferrannini E. Insulin resistance and hyperinsulinemia no independent relation to left ventricular mass in humans . Circulation. 102:2000;2233-2238.
33. Phillips R.A., Krakoff L.R., Dunaif A., Finegood D.T., Gorlin R., Shimabukuro S. Relation among left ventricular mass, insulin resistance, and blood pressure in nonobese subjects. J Clin Endocrinol Metab. 83:1998;4284-4288.